TrialJournal of clinical hypertension (Greenwich, Conn.)2017

The Impact of Azilsartan Medoxomil Treatment (Capsule Formulation) at Doses Ranging From 10 to 80 mg: Significant, Rapid Reductions in Clinic Diastolic and Systolic Blood Pressure.

Alfonso Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.